Abrams & Bayliss 'On The Line' In Biogen Fee-Shift Request
By Leslie A. Pappas ( October 14, 2021, 4:53 PM EDT) -- Pharmaceutical company Biogen Inc. narrowly avoided a shareholder's demand that it pay for driving up litigation costs in a Delaware Chancery books and records case, but its counsel Abrams & Bayliss LLP nevertheless left court Thursday with a judge's stern warning that the firm was right "on the line" of breaking the rules....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.